ImClone Settles Patent Row With Yeda, Sanofi
Biotech company ImClone Systems Inc. has inked a settlement agreement with Yeda Research and Development Company Ltd. and Sanofi-Aventis, putting to rest a patent dispute related to the cancer drug Erbitux,...To view the full article, register now.
Already a subscriber? Click here to view full article